Chris Karapetis

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

D. Tu, M. Moore, J. Zalcberg, 2015, European journal of cancer.

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.

P. Gibbs, N. Pavlakis, D. Tu, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

C. Underhill, S. Brule, C. O'Callaghan, 2015, European journal of cancer.